Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBOT for Cognitive Function and Mental Health in Veterans
NCT07214415Phase 2Recruiting
- Sponsor
- Summit Hyperbarics and Wellness
- Start
- Oct 2025
- Primary completion
- Sep 2026
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of oxygen in traumatic brain injury (TBI), post-traumatic stress disorder (PTSD), Post-concussion syndrome (PCS), anxiety disorder, major depressive disorder (MDD), sponsored by Summit Hyperbarics and Wellness. Started Oct 2025; status: recruiting.
02
Drugs
oxygen
03
Conditions
traumatic brain injury (TBI)post-traumatic stress disorder (PTSD)Post-concussion syndrome (PCS)anxiety disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07214415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07214415.